US Patent 10308943 Compositions with improved intravitreal half-life and uses thereof
Patent 10308943 was granted and assigned to Vitrisa Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10308943 Compositions with improved intravitreal half-life and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
